Wuxi Bio to Sell Vaccine Facility to Merck

WuXi Biologics to sell Ireland-based vaccine site to MSD for $500m
The transaction is expected to close in the first half of 2025, subject to the satisfaction of customary closing conditions.
WuXi Bio to Sell Vaccine Facility to Merck for $500 Million
WuXi Biologics Cayman Inc. will sell a vaccine facility in Ireland to Merck & Co. for about $500 million as the Chinese company seeks to enhance its margins while continuing to navigate geopolitical tensions.
MSD acquires WuXi's vaccine facility in Dundalk for €500m
The Dundalk site was WuXi's first manufacturing investment in Europe and the company’s first investment of this scale outside of China
Merck Buys WuXi Vaccines' Irish Manufacturing Facility For Over $500 Million
MSD acquires WuXi Vaccines' Dundalk facility with a €500 million investment, creating 1,000 new jobs across Ireland and expanding its vaccine production capabilities.
In €500M deal, Merck buys Ireland vaccines plant from CDMO WuXi Biologics
In Ireland, WuXi Biologics has sold a new vaccines plant to Merck & Co. for €500 million ($521 million). The New Jersey company was a natural buyer of the facility as it was the lone client WuXi Biologics served at the site in Dundalk, executing a 20-year contract to produce vaccines worth $150 million annually.
China's WuXi Biologics to sell Irish vaccine facility to Merck for €500m
China's WuXi Biologics has confirmed it will sell its vaccine facility in Ireland to US drugmaker Merck & Co for about €500 million. The WuXi Biologics facility is located in Dundalk, Co Louth, in the IDA Science and Technology Park.
Merck Snaps Up WuXi Biologics Facility in Ireland for $500M
The acquisition from Wuxi Biologics, the embattled CDMO named in the BIOSECURE Act, marks another expansion of Merck’s manufacturing operations in Ireland.
China’s WuXi Biologics to sell vaccine facility to Merck for US$500 million
WUXI Biologics Cayman will sell a vaccine facility in Ireland to Merck for about US$500 million as the Chinese company seeks to enhance its margins while continuing to navigate geopolitical tensions.
RTE Online2d
MSD Ireland agrees deal to buy WuXi Vaccines' Dundalk site
Pharmaceutical firm MSD has agreed a deal to buy the WuXi Vaccines manufacturing facility in Dundalk, Co Louth as part of its ...
Drug giant MSD buys Wuxi’s Irish vaccines plant in €500m deal
US pharmaceutical group adds eighth Irish manufacturing site to its network as it promises to deliver 1,000 jobs this year ...
Irish Independent on MSN3d
MSD buy out WuXi Vaccines’ Dundalk plant in €500m deal
The pharmaceutical firm MSD is buying out the WuXi Vaccines manufacturing plant in Dundalk, in a €500m deal. The American ...
IDA Ireland3d
MSD Ireland announces acquisition of WuXi Vaccines’ Dundalk site
MSD's acquisition of the WuXi Dundalk site strengthens the company’s long-standing commitment to Ireland, bringing its ...